Charles River Laboratories Intl. Inc vs PulteGroup, Inc. — how do they compare? Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B), while PulteGroup, Inc. trades at $132.77 (market cap $25.22B). The key difference: PulteGroup, Inc. is the larger of the two by market cap, and PulteGroup, Inc. pays a 0.79% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | PHM | |
|---|---|---|
Market Cap | $13.46B | $25.22B |
Sector | Health | Consumer Cyclical |
52-Week High | $282.00 | $142.56 |
52-Week Low | $145.57 | $110.11 |
Enterprise Value | $16.30B | $25.64B |
Dividend Yield | — | 0.79% |
Trailing returns across standard periods
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →